Vertex Pharmaceuticals Inc (VRTX)
401.08
+0.92
(+0.23%)
USD |
NASDAQ |
May 03, 16:00
401.11
+0.03
(+0.01%)
After-Hours: 20:00
Vertex Pharmaceuticals Max Drawdown (5Y): 41.60% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 41.60% |
March 31, 2024 | 41.60% |
February 29, 2024 | 41.60% |
January 31, 2024 | 41.60% |
December 31, 2023 | 41.60% |
November 30, 2023 | 41.60% |
October 31, 2023 | 41.60% |
September 30, 2023 | 41.60% |
August 31, 2023 | 41.60% |
July 31, 2023 | 41.60% |
June 30, 2023 | 41.60% |
May 31, 2023 | 41.60% |
April 30, 2023 | 41.60% |
March 31, 2023 | 41.60% |
February 28, 2023 | 41.60% |
January 31, 2023 | 41.60% |
December 31, 2022 | 41.60% |
November 30, 2022 | 41.60% |
October 31, 2022 | 41.60% |
September 30, 2022 | 41.60% |
August 31, 2022 | 41.60% |
July 31, 2022 | 41.60% |
June 30, 2022 | 41.60% |
May 31, 2022 | 41.60% |
April 30, 2022 | 41.60% |
Date | Value |
---|---|
March 31, 2022 | 41.60% |
February 28, 2022 | 41.60% |
January 31, 2022 | 41.60% |
December 31, 2021 | 41.60% |
November 30, 2021 | 41.60% |
October 31, 2021 | 47.07% |
September 30, 2021 | 49.10% |
August 31, 2021 | 49.10% |
July 31, 2021 | 49.10% |
June 30, 2021 | 49.10% |
May 31, 2021 | 49.10% |
April 30, 2021 | 49.10% |
March 31, 2021 | 49.10% |
February 28, 2021 | 49.10% |
January 31, 2021 | 49.10% |
December 31, 2020 | 49.10% |
November 30, 2020 | 49.10% |
October 31, 2020 | 49.10% |
September 30, 2020 | 49.10% |
August 31, 2020 | 49.10% |
July 31, 2020 | 49.10% |
June 30, 2020 | 49.10% |
May 31, 2020 | 49.10% |
April 30, 2020 | 49.10% |
March 31, 2020 | 49.10% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
41.60%
Minimum
Nov 2021
49.10%
Maximum
May 2019
45.31%
Average
44.33%
Median
Max Drawdown (5Y) Benchmarks
Amgen Inc | 24.86% |
Eli Lilly and Co | 22.48% |
Regeneron Pharmaceuticals Inc | 53.84% |
Alpine Immune Sciences Inc | 97.33% |
Editas Medicine Inc | 94.25% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 12.02 |
Beta (5Y) | 0.3868 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 26.54% |
Historical Sharpe Ratio (5Y) | 0.6152 |
Historical Sortino (5Y) | 1.014 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 9.55% |